EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Park Dental Partners, Inc. (PARK) fair value: what the stock is really worth

As of Oct 15, 2026: fair value of Park Dental Partners, Inc. $16.27, price $19.21, upside -15.3%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · ISIN US7004021009

PD Park Dental Partners, Inc. logo Thin data Oct 2, 2026

Park Dental Partners, Inc.

PARK · US

Weak valuationQuality is weak on top of the rich price.

Our calculation puts a fair price 15% below what the stock costs today.

Low debt
Generates free cash flow
Mixed Growth (revenue YoY +6.4 %/yr in USD)
Fair value $16.27 · Overvalued (−15.3%)
Quality 36/100
Loss-making · -1.4% net margin (TTM)
Trails peers (2/10)
Narrow moat 13/100 · thin data
Thin data
⚠ Dilution

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$23.05 $10.25 Fair Value $16.27 Dec 2025 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 2, 2026.

How to read this chart

10‑month range $10.25 – $23.05 · fair‑value band $16.27 – $16.27 · the $19.21 price screens above the $16.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 2, 2026.

Follow Park Dental Partners, Inc. Common Stock in your weekly email

Every Wednesday you see whether Park Dental Partners, Inc. Common Stock is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Park Dental Partners, Inc. operates as a dental resource organization that provides administrative business support services to dentists in Minnesota, Wisconsin, and Arizona.

Show moreShow less

The company offers general and specialty dental care services, such as dentist and hygiene, oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics.

It provides clinical team members, administrative personnel, and facilities and equipment to its affiliated general and multi-specialty dental practices. The company was founded in 1972 and is headquartered in Roseville, Minnesota.

Stock analysis

Park Dental Partners, Inc. Common Stock (PARK) currently trades at $19.21, while our model-based Fair Value estimate is $16.27, 15.3% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $19.17 per share, and 3 of the 14 models we run sit above the $19.21 price.

Bear case: the Earnings-Based group reads lowest at $19.12, and 11 of the 14 models stay below the price. Data coverage for this calculation is low.

Scenario range: $16.27 (bear) to $16.27 (bull), the price of $19.21 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Park Dental Partners, Inc. Common Stock reported revenue of $244M in FY2025 versus $224M in FY2023, a compound +4.6%/yr. Reported net income was −$358K in FY2025.

Key figures

Market cap $120M · P/S ratio 0.38 · EPS (TTM) $−0.7500 · Net margin −0.1% · Return on equity −24.2% · Return on assets (EBIT) −1.9% · Operating margin 1.9% · Revenue (TTM) $251M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at 20% fair-value upside, at −15%, PARK screens richer than that median.

Fair Value models

Bear $16.27 Fair Value $16.27 Bull $16.27
Price $19.21 · Upside -15.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $19.17 $19.20 $19.23 75
EPV $19.12 $19.12 $19.12 74
Growth DCF $19.17 $19.19 $19.22 73
All 14 models by family
DCF Models
FCF DCF $19.17 $19.20 $19.23 75
Owner Earnings $19.12 $19.12 $19.13 71
5Y Revenue Exit $19.14 $19.16 $19.17 67
5Y EBITDA Exit $19.18 $19.22 $19.27 70
10Y Revenue Exit $19.16 $19.17 $19.18 62
10Y EBITDA Exit $19.18 $19.21 $19.25 63
Earnings-Based
EPV $19.12 $19.12 $19.12 74
Multiples
EV/EBIT $19.13 $19.14 $19.15 66
EV/EBITDA $19.20 $19.23 $19.27 67
EV/Revenue $19.12 $19.13 $19.14 54
Asset-Based
NCAV (Graham) $0.0083 $0.0111 $0.0166 54
Growth DCF
Growth DCF $19.17 $19.19 $19.22 73
Rev-Margin DCF $19.14 $19.16 $19.17 67
Economic Profit
ROIC Compounder $19.12 $19.12 $19.12 66

Open the full fair value analysis →

Quality Score breakdown

Overall quality 36/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 33
How much profit the company makes from its sales and capital
Quality Growth 39
Are margins and returns getting better?
Cashflow 35
Do the profits arrive as real cash?
Financial strength 43
Debt, balance sheet and risk of trouble
Investment 94
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Momentum 47
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 85
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.

PARK screens overvalued: fair value 15% below the price. Compare with HCA Healthcare, Inc →

Compare Park Dental Partners, Inc. Common Stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 243 stocks

Beats the industry median on 2/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 36 · Bottom 25%
Fair Value upside −15.3% · Below median
Profitability
Return on assets −0.2% · Bottom 25%
Net margin (12 months) −1.4% · Bottom 25%
Operating margin (12 months) 1.9% · Bottom 25%
Growth and dividend
Revenue growth 5.1% · Below median
Balance sheet
Debt / equity 0.46× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 5.49× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.48× · Cheapest 25%
Price / free cash flow 11.6× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)13 · sector 33
FUTURE (revenue growth)26 · sector 27
PAST (return on equity)0 · sector 33
HEALTH (low debt)77 · sector 90
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Universal Health Services, Inc UHS $179.01 $444.19 +148% vs PARK
Fresenius Medical Care AG FMS $21.21 $45.32 +114% vs PARK
Aier Eye Hospital Group 300015 ¥7.88 ¥10.86 +38% vs PARK
HCA Healthcare, Inc HCA $458.60 $597.97 +30% vs PARK
DaVita Inc DVA $179.25 $215.81 +20% vs PARK
Tenet Healthcare Corporation THC $268.76 $274.35 +2% vs PARK
Fresenius SE FRE €42.36 €34.49 −19% vs PARK
Encompass Health Corporation EHC $123.33 $94.47 −23% vs PARK
Dr. Sulaiman Al Habib Medical Services Group 4013 225.50 SAR 109.45 SAR −51% vs PARK
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹7,775 ₹2,908 −63% vs PARK

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Park Dental Partners, Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/PARK

Frequently asked questions

Is Park Dental Partners, Inc. (PARK) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of $16.27 versus a price of $19.21, about −15% upside (overvalued).
What is the fair value of PARK?
Our model-based fair value for Park Dental Partners, Inc. Common Stock is $16.27 (as of Oct 2, 2026), built from audited fundamentals. The current price: $19.21.
What is the quality score of PARK?
Park Dental Partners, Inc. Common Stock has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Park Dental Partners, Inc. (PARK)?
Our model-based price target is the fair value of $16.27 (as of Oct 2, 2026) from 14 valuation models. Cautious scenario $16.27, optimistic scenario $16.27. It is a calculation from audited fundamentals, not an analyst target.
What is the Park Dental Partners, Inc. Common Stock stock forecast for 2026?
Our models put fair value at $16.27, about −15% upside versus a price of $19.21 (overvalued). Cautious scenario $16.27, optimistic scenario $16.27. The calculation is refreshed regularly with new filings.
What is the revenue of Park Dental Partners, Inc. (PARK)?
Park Dental Partners, Inc. Common Stock reported trailing-twelve-month revenue of about $251M (latest available figure, as of Oct 2, 2026).
What growth is priced into Park Dental Partners, Inc. (PARK)?
For today's price to be fair in a discounted-cash-flow model, Park Dental Partners, Inc. Common Stock would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +4.6 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of PARK use?
Our models discount Park Dental Partners, Inc. Common Stock at 12.7 %: a base by market capitalisation (micro), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Park Dental Partners, Inc. Common Stock that is less than minus 40 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Park Dental Partners, Inc. (PARK) delivered so far?
Over the past 2 years revenue at Park Dental Partners, Inc. Common Stock grew +4.6 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Park Dental Partners, Inc. (PARK) growing?
The median revenue growth in the sector is +5.4 % a year. That is the yardstick for the growth priced into Park Dental Partners, Inc. Common Stock (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Park Dental Partners, Inc. (PARK)?
The free-cash-flow yield on the price is 8.59 %: that much free cash flow Park Dental Partners, Inc. Common Stock produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Park Dental Partners, Inc. (PARK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Park Dental Partners, Inc. Common Stock it is $16.27 per share (as of Oct 2, 2026), against a price of $19.21. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Park Dental Partners, Inc. Common Stock stock overvalued or undervalued in 2026?
As of Oct 2, 2026, PARK trades above its calculated fair value: price $19.21, fair value $16.27, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PARK?
No. The price is what the market pays today ($19.21); the fair value is what the company's own numbers justify ($16.27). For Park Dental Partners, Inc. Common Stock the two are $2.94 per share apart. That gap is exactly why we show both numbers side by side.
How much is Park Dental Partners, Inc. Common Stock worth?
The market values Park Dental Partners, Inc. Common Stock at about $120M (market capitalisation, as of Oct 2, 2026). Per share that is $19.21; our models calculate a fair value of $16.27 per share.
What do the bullish and bearish scenarios say about PARK?
Our models span a range for Park Dental Partners, Inc. Common Stock: cautious scenario $16.27, base $16.27, optimistic $16.27 per share (as of Oct 2, 2026, price $19.21). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Park Dental Partners, Inc. (PARK)?
Balance-sheet figures for Park Dental Partners, Inc. Common Stock (as of Oct 2, 2026): return on equity −24.2%, debt of 0.46 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
Which stocks are comparable to Park Dental Partners, Inc. Common Stock?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Park Dental Partners, Inc. Common Stock stock attractive at the current price?
The data as of Oct 2, 2026: price $19.21, calculated fair value $16.27 (−15%), Quality Score 36/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PARK calculated?
We run Park Dental Partners, Inc. Common Stock through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $16.27, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Park Dental Partners, Inc. Common Stock itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Park Dental Partners, Inc. (PARK)?
The closing price on Oct 15, 2026 was $19.21. Our model-based fair value is $16.27, about −15% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Park Dental Partners, Inc. Common Stock right now?
The price sits above even our optimistic bull case ($16.27). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The models converge in a tight band ($16.27 to $16.27), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Park Dental Partners, Inc. Common Stock

How large is the market capitalisation of Park Dental Partners, Inc. (PARK)?
The market capitalisation of Park Dental Partners, Inc. Common Stock is $120M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Park Dental Partners, Inc. (PARK)?
The price-to-sales ratio of Park Dental Partners, Inc. Common Stock is 0.38 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Park Dental Partners, Inc. (PARK)?
Earnings per share at Park Dental Partners, Inc. Common Stock are $−0.7500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Park Dental Partners, Inc. (PARK)?
The net margin of Park Dental Partners, Inc. Common Stock is −0.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Park Dental Partners, Inc. (PARK)?
The return on equity (ROE) of Park Dental Partners, Inc. Common Stock is −24.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Park Dental Partners, Inc. (PARK)?
On an EBIT basis the return on assets of Park Dental Partners, Inc. Common Stock is −1.9% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Park Dental Partners, Inc. (PARK)?
The operating margin of Park Dental Partners, Inc. Common Stock is 1.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Park Dental Partners, Inc. (PARK)?
Revenue at Park Dental Partners, Inc. Common Stock is growing +5.1% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Park Dental Partners, Inc. (PARK)?
Earnings per share at Park Dental Partners, Inc. Common Stock are growing −84.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Park Dental Partners, Inc. (PARK) hold?
Park Dental Partners, Inc. Common Stock holds more cash than debt, $25.1B net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Park Dental Partners, Inc. Common Stock in the live analysis

One click puts Park Dental Partners, Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.